Centiva Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.37M | Hold |
140,000
| – | – | 0.03% | 334 |
|
|
2026
Q1 | $3.93M | Sell |
140,000
-250,000
| -64% | -$6.66M | 0.03% | 315 |
|
|
2025
Q4 | $9.71M | Buy |
390,000
+250,000
| +179% | +$6.3M | 0.08% | 165 |
|
|
2025
Q3 | $3.57M | Hold |
140,000
| – | – | 0.03% | 284 |
|
|
2025
Q2 | $3.39M | Buy |
+140,000
| New | +$3.26M | 0.06% | 209 |
|
|
2024
Q4 | – | Sell |
-14,200
| Closed | -$411K | – | 2230 |
|
|
2024
Q3 | $411K | Sell |
14,200
-26,400
| -65% | -$770K | 0.01% | 1384 |
|
|
2024
Q2 | $1.14M | Sell |
40,600
-14,500
| -26% | -$399K | 0.02% | 712 |
|
|
2024
Q1 | $1.53M | Sell |
55,100
-123,000
| -69% | -$3.41M | 0.04% | 448 |
|
|
2023
Q4 | $5.13M | Buy |
178,100
+157,600
| +769% | +$4.76M | 0.12% | 155 |
|
|
2023
Q3 | $680K | Buy |
+20,500
| New | +$725K | 0.02% | 813 |
|
|
2023
Q2 | – | Sell |
-10,200
| Closed | -$416K | – | 1906 |
|
|
2023
Q1 | $416K | Sell |
10,200
-41,500
| -80% | -$1.79M | 0.01% | 915 |
|
|
2022
Q4 | $2.65M | Buy |
51,700
+35,000
| +210% | +$1.68M | 0.07% | 273 |
|
|
2022
Q3 | $731K | Sell |
16,700
-5,000
| -23% | -$243K | 0.01% | 742 |
|
|
2022
Q2 | $1.14M | Buy |
21,700
+10,700
| +97% | +$545K | 0.03% | 550 |
|
|
2022
Q1 | $570K | Sell |
11,000
-120,900
| -92% | -$6.27M | 0.01% | 917 |
|
|
2021
Q4 | $7.79M | Buy |
131,900
+124,720
| +1,737% | +$6.18M | 0.16% | 120 |
|
|
2021
Q3 | $311K | Buy |
7,180
+5,180
| +259% | +$229K | 0.02% | 774 |
|
|
2021
Q2 | $78K | Sell |
2,000
-22,500
| -92% | -$875K | ﹤0.01% | 1276 |
|
|
2021
Q1 | $887K | Sell |
24,500
-301,600
| -92% | -$10.7M | 0.03% | 402 |
|
|
2020
Q4 | $12M | Buy |
+326,100
| New | +$12M | 0.47% | 36 |
|
|
2020
Q3 | – | Sell |
-105
| Closed | -$3K | – | 838 |
|
|
2020
Q2 | $3K | Hold |
105
| – | – | ﹤0.01% | 645 |
|
|
2020
Q1 | $3K | Buy |
+105
| New | +$3.58K | ﹤0.01% | 571 |
|
|
2019
Q1 | – | Sell |
-64,294
| Closed | -$2.66M | – | 357 |
|
|
2018
Q4 | $2.66M | Hold |
64,294
| – | – | 0.21% | 67 |
|
|
2018
Q3 | $2.69M | Buy |
64,294
+50,170
| +355% | +$1.93M | 0.23% | 66 |
|
|
2018
Q2 | $487K | Sell |
14,124
-47,535
| -77% | -$1.62M | 0.1% | 59 |
|
|
2018
Q1 | $2.08M | Buy |
+61,659
| New | +$2.12M | 0.5% | 18 |
|
Other funds holding PFE
Centiva Capital's PFE Position: Q2 2026 in Review
Centiva Capital increased its Pfizer (PFE) stake by 74% in Q2 2026, buying an estimated $10M and bringing the position to 899,074 shares worth $21.6M. The position accounts for 0.19% of the portfolio, ranked #98.
Centiva Capital first reported a position in PFE in Q3 2018 and has held it in 26 quarters since. The position peaked at $22.1M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Centiva Capital held 899,074 shares of Pfizer worth $21.6M as of Q2 2026.
- Centiva Capital bought 383,579 Pfizer shares in Q2 2026, an estimated $10M.
- Pfizer made up 0.19% of Centiva Capital's portfolio in Q2 2026, its #98 holding.
- Centiva Capital first reported a position in Pfizer in Q3 2018 and has held it in 26 quarters since.
- Centiva Capital's Pfizer position peaked at $22.1M in Q4 2021.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.